SEC Form 8-K Summary
Registrant: Jupiter Wellness, Inc. (the filing content does not identify BONK, Inc. as the registrant). The report concerns an event dated January 20, 2022 and was signed January 26, 2022.
Business Context and Reporting Period
The filing reports a Nasdaq listing-compliance matter under Listing Rule 5635(c), which requires stockholder approval for certain equity compensation arrangements involving officers, directors, employees, or consultants.
Key Financial and Capitalization Information
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.
- During the first nine months of 2021, the Company issued 1,020,000 common shares to consultants outside the 2021 Equity Incentive Plan.
- Of those shares, 180,000 issued to three consultants were determined to be S-8 eligible and should have been issued under the 2021 Equity Plan: Greentree Financial, Inc. received 100,000 shares; L&H Inc. received 20,000 shares; and Tee 2 Green Enterprises, Ltd. received 60,000 shares.
- To facilitate reallocation of these awards, the Board cancelled 100,000 options previously issued to CEO and director Brian John and 100,000 options previously issued to Chief Science Officer and Chairman Glynn Wilson. Both agreed to the cancellations.
Material Changes and Resolution
The Company’s internal investigation and communications with Nasdaq determined that the 180,000 consultant share grants did not comply with Nasdaq Listing Rule 5635(c). The Board approved reallocating the grants to the 2021 Equity Plan and updated the Company’s books and records.
On January 20, 2022, Nasdaq notified the Company that it had regained compliance with Rule 5635(c) and that the matter was closed. The filing does not disclose any delisting, trading suspension, cash payment, or fine.
Guidance, Risks, and Unusual Items
- No financial guidance or operating outlook was provided.
- The principal risk involved inadvertent noncompliance with Nasdaq’s equity-compensation rules and the potential listing implications.
- The corrective action reduced outstanding options held by two senior executives by an aggregate of 200,000 options and reclassified 180,000 consultant share grants for plan-accounting purposes.
- The filing states that the Company believed in good faith that the consulting awards were not S-8 eligible when issued.
Investor Verification Items
- Confirm the correct registrant, because the supplied metadata names BONK, Inc., while the filing identifies Jupiter Wellness, Inc.
- Verify the final capitalization impact of the 180,000 reallocated shares and 200,000 cancelled executive options.
- Review the 2021 Equity Plan and subsequent filings for any additional amendments, awards, or dilution.
- Confirm Nasdaq’s January 20, 2022 compliance determination and whether any related disclosures appeared in later filings.